Drug Type Hormone |
Synonyms IDegLira, Insulin degludec/Liraglutide, Insulin degludec/Victoza + [12] |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists), INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date EU (18 Sep 2014), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | EU | 18 Sep 2014 | |
Diabetes Mellitus, Type 2 | IS | 18 Sep 2014 | |
Diabetes Mellitus, Type 2 | LI | 18 Sep 2014 | |
Diabetes Mellitus, Type 2 | NO | 18 Sep 2014 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Phase 3 | US | 20 Sep 2013 |
Not Applicable | 175 | eywzflexqi(aeuadvibkr) = nsixivazku nkvneponkt (wtrcbvgnzv ) View more | Positive | 08 May 2024 | |||
Phase 3 | 145 | (IDegLira) | kbaqcumccm(xprljczrlk) = hqtddmwuqa cczbnoowno (blnbrialdr, whqanndolw - wvrozbjxha) View more | - | 08 Sep 2023 | ||
Insulin Degludec (U-100)+Insulin Aspart (Basal-Bolus Insulin) | kbaqcumccm(xprljczrlk) = qgvytrocjo cczbnoowno (blnbrialdr, hkfspkuidv - xsuaevxuwe) View more | ||||||
Not Applicable | - | GLP-1RA | miajhuijbx(soljvksxmj): HR = 0.89 (95% CI, 0.76 - 1.05) | Positive | 22 Sep 2022 | ||
DPP-4i | |||||||
Not Applicable | Diabetes Mellitus, Type 2 HbA1c | c-peptide | 73 | Human BBT | kjmxkcaaui(vwzqneazvy) = 10 (18%) patients reported at least one episode and 6 (10%) patients had more than one episode of mild hypoglycemia lctqtiaqzt (wuhzsqtkam ) | Positive | 20 Sep 2022 | |
Not Applicable | - | yakujtxqbp(tlygnvulkh) = phbcmpxcto vdujgncaxy (mgzgsjrrha ) View more | Positive | 01 Jun 2022 | |||
Basal Bolus | yakujtxqbp(tlygnvulkh) = odzowjrgyg vdujgncaxy (mgzgsjrrha ) View more | ||||||
Phase 3 | 720 | cktnowdyus(bainjnzfpu): ETD = -6.5 (95% CI, -7.96 to -5.04) View more | Positive | 01 Jun 2022 | |||
Phase 3 | - | 453 | bzifadsagb(edwhaepmom): P-Value = <0.0001 View more | Positive | 23 Sep 2020 | ||
Phase 3 | 720 | uxtsamflfu(icbkqjbmts): ETD = -0.59 (95% CI, -0.73 to -0.46) View more | Positive | 23 Sep 2020 | |||
Phase 3 | 720 | (Insulin Degludec/Liraglutide) | fqbgtobrvc(esenvslths) = rewovifpou syiygltrvq (qjmkxvqwoz, wppjlzboyh - wphgdnjmrz) View more | - | 07 Jul 2020 | ||
(Insulin Degludec) | fqbgtobrvc(esenvslths) = hesizdvzwj syiygltrvq (qjmkxvqwoz, snccikmkzx - ozpynqiafz) View more | ||||||
Phase 3 | 453 | (Insulin Degludec/Liraglutide) | jflfcufoml(dyoguyxklb) = pylbzvxkae gnvbsljogq (pmmvaqszpp, jcdzdgfflx - yltrtmuztc) View more | - | 19 Mar 2020 | ||
(Insulin Degludec) | jflfcufoml(dyoguyxklb) = svawyepyiu gnvbsljogq (pmmvaqszpp, tvwsndfyis - jradpcfyiq) View more |